TRIM37 is a new histone H2A ubiquitin ligase and breast cancer oncoprotein

Nature

Volumn 516, Issue 729, 2014, Pages 116-120

  Bhatnagar, Sanchita ^a   Gazin, Claude ^b   Chamberlain, Lynn ^a   Ou, Jianhong ^a   Zhu, Xiaochun ^a   Tushir, Jogender S ^c   Virbasius, Ching Man ^a   Lin, Ling ^a   Zhu, Lihua J ^a   Wajapeyee, Narendra ^d   Green, Michael R ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b DIF   (France)

^c BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BMI1 PROTEIN; COMPLEMENTARY DNA; HISTONE H2A; ONCOPROTEIN; POLYCOMB REPRESSIVE COMPLEX 2; PROTEIN RNF2; PROTEIN TRIM37; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR EZH2; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; HISTONE; NUCLEAR PROTEIN; RNF2 PROTEIN, HUMAN; TRIM37 PROTEIN, HUMAN;

CANCER; CHROMOSOME; GENE EXPRESSION; PROTEIN; RNA; RODENT; TUMOR; WOMENS HEALTH;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CANCER INHIBITION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EXPRESSION VECTOR; FEMALE; GENE EXPRESSION; GENE SILENCING; HISTONE UBIQUITINATION; HUMAN; HUMAN CELL; MCF 7 CELL LINE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE; 3T3 CELL LINE; ANIMAL; BREAST TUMOR; ENZYMOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; XENOGRAFT;

ANIMALS; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HETEROGRAFTS; HISTONES; HUMANS; MCF-7 CELLS; MICE; NIH 3T3 CELLS; NUCLEAR PROTEINS; ONCOGENE PROTEINS; POLYCOMB REPRESSIVE COMPLEX 1;

EID: 84923196763     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature13955     Document Type: Article

References (42)

1. Sinclair, C. S., Rowley, M., Naderi, A. & Couch, F. J. The 17q23 amplicon and breast cancer. Breast Cancer Res. Treat. 78, 313-322 (2003).
2. Budhidarmo, R., Nakatani, Y. & Day, C. L. RINGs hold the key to ubiquitin transfer. Trends Biochem. Sci. 37, 58-65 (2012).
3. Weake, V. M. & Workman, J. L. Histone ubiquitination: triggering gene activity. Mol. Cell 29, 653-663 (2008).
4. Wang, H. et al. Role of histone H2A ubiquitination in Polycomb silencing. Nature 431, 873-878 (2004).
5. de Napoles, M. et al. Polycomb group proteins Ring1A/B link ubiquitylation of histone H2A to heritable gene silencing and X inactivation. Dev. Cell 7, 663-676 (2004).
6. Gazin, C., Wajapeyee, N., Gobeil, S., Virbasius, C. M. & Green, M. R. An elaborate pathway required for Ras-mediated epigenetic silencing. Nature 449, 1073-1077 (2007).
7. Cao, R., Tsukada, Y. & Zhang, Y. Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing. Mol. Cell 20, 845-854 (2005).
8. Lanzuolo, C.Orlando, V.Memories fromthe polycombgroup proteins. Annu. Rev. Genet. 46, 561-589 (2012).
9. Buchwald, G. et al. Structure and E3-ligase activity of the Ring-Ring complex of polycomb proteins Bmi1 and Ring1b. EMBO J. 25, 2465-2474 (2006).
10. Richly, H. et al. Transcriptional activation of polycomb-repressed genes by ZRF1. Nature 468, 1124-1128 (2010).
11. Monni, O. et al. Comprehensive copy number and gene expression profiling of the 17q23ampliconinhumanbreast cancer. Proc.Natl Acad. Sci.USA98,5711-5716 (2001).
12. Kirmizis, A. et al. Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27. Genes Dev. 18, 1592-1605 (2004).
13. Margueron, R. & Reinberg, D. The Polycomb complex PRC2 and its mark in life. Nature 469, 343-349 (2011).
14. Ku, M. et al. Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains. PLoS Genet. 4, e1000242 (2008).
15. Mohn, F. et al. Lineage-specific polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors. Mol. Cell 30, 755-766 (2008).
16. Velichutina, I. et al. EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis. Blood 116, 5247-5255 (2010).
17. Orlando, D. A.,Guenther, M. G., Frampton, G. M.Young, R. A. CpG island structure and trithorax/polycomb chromatin domains in human cells. Genomics 100, 320-326 (2012).
18. Riising, E. M. et al. Gene silencing triggers polycomb repressive complex 2 recruitment to CpG islands genome wide. Mol. Cell 55, 347-360 (2014).
19. Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 490, 61-70 (2012).
20. Miller, F. R. et al. Xenograft model of progressive human proliferative breast disease. J. Natl. Cancer Inst. 85, 1725-1732 (1993).
21. Ince, T. A. et al. Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes. Cancer Cell 12, 160-170 (2007).
22. von Lintig, F. C. et al. Ras activation in human breast cancer. Breast Cancer Res. Treat. 62, 51-62 (2000).
23. Grau, D. J. et al. Compaction of chromatin by diverse Polycomb group proteins requires localized regions of high charge. Genes Dev. 25, 2210-2221 (2011).
24. Eskeland, R. et al. Ring1B compacts chromatin structure and represses gene expression independent of histone ubiquitination. Mol. Cell 38, 452-464 (2010).
25. Chang, C. J. & Hung, M. C. The role of EZH2 in tumour progression. Br. J. Cancer 106, 243-247 (2012).
26. Deb, G., Thakur, V. S. & Gupta, S. Multifaceted role of EZH2 in breast and prostate tumorigenesis: epigenetics and beyond. Epigenetics 8, 464-476 (2013).
27. Dawson, P. J., Wolman, S. R., Tait, L., Heppner, G. H. & Miller, F. R. MCF10AT: a model for the evolution of cancer from proliferative breast disease. Am. J. Pathol. 148, 313-319 (1996).
28. Fernandez, S. V. et al. Inflammatory breast cancer (IBC): clues for targeted therapies. Breast Cancer Res. Treat. 140, 23-33 (2013).
29. Luger, K., Rechsteiner, T. J. & Richmond, T. J. Expression and purification of recombinant histones and nucleosome reconstitution. Methods Mol. Biol. 119, 1-16 (1999).
30. Hansen, J. C., Ausio, J., Stanik, V. H. & van Holde, K. E. Homogeneous reconstituted oligonucleosomes, evidence for salt-dependent folding in the absence of histone H1. Biochemistry 28, 9129-9136 (1989).
31. Maston, G. A. et al. Non-canonical TAF complexes regulate active promoters in human embryonic stem cells. eLife 1, e00068 (2012).
32. Gentleman, R. C. et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5, R80 (2004).
33. Zacher, B., Kuan, P. F.Tresch, A. Starr: Simple Tiling ARRay analysis of Affymetrix ChIP-chip data. BMC Bioinformatics 11, 194 (2010).
34. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statist. Soc. B 57, 289-300 (1995).
35. Zhu, L. J. et al. ChIPpeakAnno: a Bioconductor package to annotate ChIP-seq and ChIP-chip data. BMC Bioinformatics 11, 237 (2010).
36. Salicrú , M., Ocana, J. & Sanchez-Pla, A. Comparison of lists of genes based on functional profiles. BMC Bioinformatics 12, 401 (2011).
37. Ihaka, R. & Gentleman, R. R: a language for data analysis and graphics. J. Comput. Graph. Stat. 5, 299-314 (1996).
38. Edgar, R., Domrachev, M. & Lash, A. E. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30, 207-210 (2002).
39. Tanese, N. Small-scale density gradient sedimentation to separate and analyze multiprotein complexes. Methods 12, 224-234 (1997).
40. Wang, Y. et al.BASC,a super complex ofBRCA1-associatedproteins involved in the recognition and repair of aberrant DNA structures. Genes Dev. 14, 927-939 (2000).
41. Liu, F. & Green, M. R. A specific member of the ATF transcription factor family can mediate transcription activation by the adenovirus E1a protein. Cell 61, 1217-1224 (1990).
42. Lillie, J. W. & Green, M. R. Transcription activation by the adenovirus E1a protein. Nature 338, 39-44 (1989).